Impact of radiofrequency exposure on preterm newborns
Radiofrequency Fields in Neonatology: Exposure and Impact on the Nervous System
This study is trying to see how much radiofrequency exposure preterm newborns get in hospitals and if it affects their brain and nervous system health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 1 Day to 1 Month |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Amiens, Picardie) |
| Trial ID | NCT06281093 on ClinicalTrials.gov |
What this trial studies
This study investigates the levels of radiofrequency (RF) exposure that preterm newborns experience in various neonatal intensive care units (NICUs) across France. It aims to quantify the continuous and individual RF exposure for each infant during their hospital stay and assess its potential effects on their central and peripheral nervous systems. The study will involve daily monitoring of RF levels, clinical parameters, and recording of cerebral and autonomic nervous system activity through EEG and ECG. The goal is to determine if RF exposure impacts neurophysiological functions in preterm infants.
Who should consider this trial
Good fit: Ideal candidates for this study are preterm newborns born between 26-34 weeks of gestational age.
Not a fit: Patients who may not benefit from this study include those with infections, neurological disorders, or serious health conditions, as well as infants born to mothers under 18 or deprived of parental rights.
Why it matters
Potential benefit: If successful, this study could provide insights into the safety of NICU environments and inform guidelines to protect vulnerable preterm newborns from potential neurophysiological harm.
How similar studies have performed: While previous studies have indicated potential impacts of RF exposure on preterm infants, this study's approach of quantifying exposure across multiple NICUs is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * preterm newborns born between 26-34 weeks of gestational age Exclusion Criteria: * infants infected, * suffering from neurological disorders, * serious heart, respiratory, digestive or metabolic diseases; * infants born from mothers aged less than 18 years old or deprived of their parental rights
Where this trial is running
Amiens, Picardie
- Amiens University Hospital — Amiens, Picardie, France (Recruiting)
Study contacts
- Study coordinator: Erwan STÉPHAN-BLANCHARD, Dr
- Email: erwan.stephan@u-picardie.fr
- Phone: 03 22 82 78 65
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.